Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay

Autores
Vazquez, Carolina; Gutierrez-Acevedo, María Nelly; Barbero, Sabrina; Notari, Lorena del Carmen; Agozino, Marina; Fernandez, José Luis; Anders, María Margarita; Grigera, Nadia Lorena; Antinucci, Florencia; Orozco Ganem, Orlando Nicolas Federico; Murga, María Dolores; Perez, María Daniela; Palazzo, Ana Gracia; Rejtman, Liria Martinez; Duarte, Ivonne Giselle; Vorobioff, Julio Daniel; Trevizan, Victoria; Bulaty, Sofía; Bessone, Fernando; Valverde, Marcelo; Elizondo, Martín; Borzi, Silvia Mabel; Stieben, Teodoro Eduardo; Masola, Adriano Carlos; Tomatis, Jesica; Pages, Josefina; Tevez, Silvina; Gadano, Adrián Carlos; Giunta, Diego Hernan; Marciano, Sebastián
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Introduction and Objectives: there is insufficient data regarding bacterial infections in patients with cirrhosis to support recommendations for empiric antibiotic treatments, particularly in Latin America. This study aimed to evaluate bacterial infection's clinical impact and microbiological characteristics, intending to serve as a platform to revise current practices. Materials and Methods: multicenter prospective cohort study of patients with cirrhosis and bacterial infections from Argentina and Uruguay. Patient and infection-related information were collected, focusing on microbiology, antibiotic susceptibility patterns, and outcomes. Results: 472 patients were included. Spontaneous bacterial infections and urinary tract infections (UTIs) were registered in 187 (39.6%) and 116 (24.6%) patients, respectively, representing the most common infections. Of the 256 culture-positive infections, 103 (40.2%) were caused by multidrug-resistant organisms (reaching 50% for UTI), and 181 (70.7%) received adequate initial antibiotic treatment. The coverage of cefepime and ceftriaxone was over 70% for the empirical treatment of community-acquired spontaneous infections, but ceftazidime´s coverage was only 40%. For all UTI cases and for healthcare-associated or nosocomial spontaneous bacterial infections, the lower-spectrum antibiotics that covered at least 70% of the isolations were imipenem and meropenem. During hospitalization, a second bacterial infection was diagnosed in 9.8% of patients, 23.9% required at least one organ support, and 19.5% died. Conclusions: short-term mortality of bacterial infections in patients with cirrhosis is very high, and a high percentage were caused by multidrug-resistant organisms, particularly in UTIs. The information provided might serve to adapt recommendations, particularly related to empirical antibiotic treatment in Argentina and Uruguay. The study was registered in Clinical Trials (NCT03919032).
Fil: Vazquez, Carolina. Hospital Italiano; Argentina
Fil: Gutierrez-Acevedo, María Nelly. Hospital 4 de Junio; Argentina
Fil: Barbero, Sabrina. Complejo Medico Policial Bartolome Churruca Andres Visca; Argentina
Fil: Notari, Lorena del Carmen. Complejo Medico Policial Bartolome Churruca Andres Visca; Argentina
Fil: Agozino, Marina. Sanatorio Guemes; Argentina
Fil: Fernandez, José Luis. Sanatorio Guemes; Argentina
Fil: Anders, María Margarita. Hospital Alemán; Argentina
Fil: Grigera, Nadia Lorena. Hospital Aleman; Argentina
Fil: Antinucci, Florencia. Hospital Alemán; Argentina
Fil: Orozco Ganem, Orlando Nicolas Federico. Hospital Alemán; Argentina
Fil: Murga, María Dolores. Hospital A. C. Padilla; Argentina
Fil: Perez, María Daniela. Hospital A. C. Padilla; Argentina
Fil: Palazzo, Ana Gracia. Hospital A. C. Padilla; Argentina
Fil: Rejtman, Liria Martinez. Hospital Teodoro J. Schestakow; Argentina
Fil: Duarte, Ivonne Giselle. Hospital 4 de Junio; Argentina
Fil: Vorobioff, Julio Daniel. Hospital Provincial del Centenario; Argentina
Fil: Trevizan, Victoria. Hospital Provincial del Centenario; Argentina
Fil: Bulaty, Sofía. Hospital Provincial del Centenario; Argentina
Fil: Bessone, Fernando. Hospital Provincial del Centenario; Argentina
Fil: Valverde, Marcelo. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Elizondo, Martín. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Borzi, Silvia Mabel. Hospital Prof. Rodolfo Rossi; Argentina
Fil: Stieben, Teodoro Eduardo. Provincia de Entre Rios. Hospital San Martin; Argentina
Fil: Masola, Adriano Carlos. Provincia de Entre Rios. Hospital San Martin; Argentina
Fil: Tomatis, Jesica. Hospital Privado de Rosario; Argentina
Fil: Pages, Josefina. Universidad Austral; Argentina
Fil: Tevez, Silvina. Sanatorio Guemes; Argentina
Fil: Gadano, Adrián Carlos. Hospital Italiano; Argentina
Fil: Giunta, Diego Hernan. Hospital Italiano; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Marciano, Sebastián. Hospital Italiano; Argentina
Materia
ANTIBIOTICS
ANTIMICROBIAL AGENTS
MULTIDRUG RESISTANCE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/221031

id CONICETDig_47179d08822ec6f51fe0974e5409000e
oai_identifier_str oai:ri.conicet.gov.ar:11336/221031
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and UruguayVazquez, CarolinaGutierrez-Acevedo, María NellyBarbero, SabrinaNotari, Lorena del CarmenAgozino, MarinaFernandez, José LuisAnders, María MargaritaGrigera, Nadia LorenaAntinucci, FlorenciaOrozco Ganem, Orlando Nicolas FedericoMurga, María DoloresPerez, María DanielaPalazzo, Ana GraciaRejtman, Liria MartinezDuarte, Ivonne GiselleVorobioff, Julio DanielTrevizan, VictoriaBulaty, SofíaBessone, FernandoValverde, MarceloElizondo, MartínBorzi, Silvia MabelStieben, Teodoro EduardoMasola, Adriano CarlosTomatis, JesicaPages, JosefinaTevez, SilvinaGadano, Adrián CarlosGiunta, Diego HernanMarciano, SebastiánANTIBIOTICSANTIMICROBIAL AGENTSMULTIDRUG RESISTANCEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Introduction and Objectives: there is insufficient data regarding bacterial infections in patients with cirrhosis to support recommendations for empiric antibiotic treatments, particularly in Latin America. This study aimed to evaluate bacterial infection's clinical impact and microbiological characteristics, intending to serve as a platform to revise current practices. Materials and Methods: multicenter prospective cohort study of patients with cirrhosis and bacterial infections from Argentina and Uruguay. Patient and infection-related information were collected, focusing on microbiology, antibiotic susceptibility patterns, and outcomes. Results: 472 patients were included. Spontaneous bacterial infections and urinary tract infections (UTIs) were registered in 187 (39.6%) and 116 (24.6%) patients, respectively, representing the most common infections. Of the 256 culture-positive infections, 103 (40.2%) were caused by multidrug-resistant organisms (reaching 50% for UTI), and 181 (70.7%) received adequate initial antibiotic treatment. The coverage of cefepime and ceftriaxone was over 70% for the empirical treatment of community-acquired spontaneous infections, but ceftazidime´s coverage was only 40%. For all UTI cases and for healthcare-associated or nosocomial spontaneous bacterial infections, the lower-spectrum antibiotics that covered at least 70% of the isolations were imipenem and meropenem. During hospitalization, a second bacterial infection was diagnosed in 9.8% of patients, 23.9% required at least one organ support, and 19.5% died. Conclusions: short-term mortality of bacterial infections in patients with cirrhosis is very high, and a high percentage were caused by multidrug-resistant organisms, particularly in UTIs. The information provided might serve to adapt recommendations, particularly related to empirical antibiotic treatment in Argentina and Uruguay. The study was registered in Clinical Trials (NCT03919032).Fil: Vazquez, Carolina. Hospital Italiano; ArgentinaFil: Gutierrez-Acevedo, María Nelly. Hospital 4 de Junio; ArgentinaFil: Barbero, Sabrina. Complejo Medico Policial Bartolome Churruca Andres Visca; ArgentinaFil: Notari, Lorena del Carmen. Complejo Medico Policial Bartolome Churruca Andres Visca; ArgentinaFil: Agozino, Marina. Sanatorio Guemes; ArgentinaFil: Fernandez, José Luis. Sanatorio Guemes; ArgentinaFil: Anders, María Margarita. Hospital Alemán; ArgentinaFil: Grigera, Nadia Lorena. Hospital Aleman; ArgentinaFil: Antinucci, Florencia. Hospital Alemán; ArgentinaFil: Orozco Ganem, Orlando Nicolas Federico. Hospital Alemán; ArgentinaFil: Murga, María Dolores. Hospital A. C. Padilla; ArgentinaFil: Perez, María Daniela. Hospital A. C. Padilla; ArgentinaFil: Palazzo, Ana Gracia. Hospital A. C. Padilla; ArgentinaFil: Rejtman, Liria Martinez. Hospital Teodoro J. Schestakow; ArgentinaFil: Duarte, Ivonne Giselle. Hospital 4 de Junio; ArgentinaFil: Vorobioff, Julio Daniel. Hospital Provincial del Centenario; ArgentinaFil: Trevizan, Victoria. Hospital Provincial del Centenario; ArgentinaFil: Bulaty, Sofía. Hospital Provincial del Centenario; ArgentinaFil: Bessone, Fernando. Hospital Provincial del Centenario; ArgentinaFil: Valverde, Marcelo. Hospital de Clinicas Dr. Manuel Quintela; UruguayFil: Elizondo, Martín. Hospital de Clinicas Dr. Manuel Quintela; UruguayFil: Borzi, Silvia Mabel. Hospital Prof. Rodolfo Rossi; ArgentinaFil: Stieben, Teodoro Eduardo. Provincia de Entre Rios. Hospital San Martin; ArgentinaFil: Masola, Adriano Carlos. Provincia de Entre Rios. Hospital San Martin; ArgentinaFil: Tomatis, Jesica. Hospital Privado de Rosario; ArgentinaFil: Pages, Josefina. Universidad Austral; ArgentinaFil: Tevez, Silvina. Sanatorio Guemes; ArgentinaFil: Gadano, Adrián Carlos. Hospital Italiano; ArgentinaFil: Giunta, Diego Hernan. Hospital Italiano; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Marciano, Sebastián. Hospital Italiano; ArgentinaMexican Association of Hepatology2023-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/221031Vazquez, Carolina; Gutierrez-Acevedo, María Nelly; Barbero, Sabrina; Notari, Lorena del Carmen; Agozino, Marina; et al.; Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay; Mexican Association of Hepatology; Annals of Hepatology; 28; 4; 7-2023; 1-81665-2681CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.aohep.2023.101097info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1665268123002016info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:37:32Zoai:ri.conicet.gov.ar:11336/221031instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:37:33.284CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
title Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
spellingShingle Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
Vazquez, Carolina
ANTIBIOTICS
ANTIMICROBIAL AGENTS
MULTIDRUG RESISTANCE
title_short Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
title_full Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
title_fullStr Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
title_full_unstemmed Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
title_sort Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
dc.creator.none.fl_str_mv Vazquez, Carolina
Gutierrez-Acevedo, María Nelly
Barbero, Sabrina
Notari, Lorena del Carmen
Agozino, Marina
Fernandez, José Luis
Anders, María Margarita
Grigera, Nadia Lorena
Antinucci, Florencia
Orozco Ganem, Orlando Nicolas Federico
Murga, María Dolores
Perez, María Daniela
Palazzo, Ana Gracia
Rejtman, Liria Martinez
Duarte, Ivonne Giselle
Vorobioff, Julio Daniel
Trevizan, Victoria
Bulaty, Sofía
Bessone, Fernando
Valverde, Marcelo
Elizondo, Martín
Borzi, Silvia Mabel
Stieben, Teodoro Eduardo
Masola, Adriano Carlos
Tomatis, Jesica
Pages, Josefina
Tevez, Silvina
Gadano, Adrián Carlos
Giunta, Diego Hernan
Marciano, Sebastián
author Vazquez, Carolina
author_facet Vazquez, Carolina
Gutierrez-Acevedo, María Nelly
Barbero, Sabrina
Notari, Lorena del Carmen
Agozino, Marina
Fernandez, José Luis
Anders, María Margarita
Grigera, Nadia Lorena
Antinucci, Florencia
Orozco Ganem, Orlando Nicolas Federico
Murga, María Dolores
Perez, María Daniela
Palazzo, Ana Gracia
Rejtman, Liria Martinez
Duarte, Ivonne Giselle
Vorobioff, Julio Daniel
Trevizan, Victoria
Bulaty, Sofía
Bessone, Fernando
Valverde, Marcelo
Elizondo, Martín
Borzi, Silvia Mabel
Stieben, Teodoro Eduardo
Masola, Adriano Carlos
Tomatis, Jesica
Pages, Josefina
Tevez, Silvina
Gadano, Adrián Carlos
Giunta, Diego Hernan
Marciano, Sebastián
author_role author
author2 Gutierrez-Acevedo, María Nelly
Barbero, Sabrina
Notari, Lorena del Carmen
Agozino, Marina
Fernandez, José Luis
Anders, María Margarita
Grigera, Nadia Lorena
Antinucci, Florencia
Orozco Ganem, Orlando Nicolas Federico
Murga, María Dolores
Perez, María Daniela
Palazzo, Ana Gracia
Rejtman, Liria Martinez
Duarte, Ivonne Giselle
Vorobioff, Julio Daniel
Trevizan, Victoria
Bulaty, Sofía
Bessone, Fernando
Valverde, Marcelo
Elizondo, Martín
Borzi, Silvia Mabel
Stieben, Teodoro Eduardo
Masola, Adriano Carlos
Tomatis, Jesica
Pages, Josefina
Tevez, Silvina
Gadano, Adrián Carlos
Giunta, Diego Hernan
Marciano, Sebastián
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ANTIBIOTICS
ANTIMICROBIAL AGENTS
MULTIDRUG RESISTANCE
topic ANTIBIOTICS
ANTIMICROBIAL AGENTS
MULTIDRUG RESISTANCE
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Introduction and Objectives: there is insufficient data regarding bacterial infections in patients with cirrhosis to support recommendations for empiric antibiotic treatments, particularly in Latin America. This study aimed to evaluate bacterial infection's clinical impact and microbiological characteristics, intending to serve as a platform to revise current practices. Materials and Methods: multicenter prospective cohort study of patients with cirrhosis and bacterial infections from Argentina and Uruguay. Patient and infection-related information were collected, focusing on microbiology, antibiotic susceptibility patterns, and outcomes. Results: 472 patients were included. Spontaneous bacterial infections and urinary tract infections (UTIs) were registered in 187 (39.6%) and 116 (24.6%) patients, respectively, representing the most common infections. Of the 256 culture-positive infections, 103 (40.2%) were caused by multidrug-resistant organisms (reaching 50% for UTI), and 181 (70.7%) received adequate initial antibiotic treatment. The coverage of cefepime and ceftriaxone was over 70% for the empirical treatment of community-acquired spontaneous infections, but ceftazidime´s coverage was only 40%. For all UTI cases and for healthcare-associated or nosocomial spontaneous bacterial infections, the lower-spectrum antibiotics that covered at least 70% of the isolations were imipenem and meropenem. During hospitalization, a second bacterial infection was diagnosed in 9.8% of patients, 23.9% required at least one organ support, and 19.5% died. Conclusions: short-term mortality of bacterial infections in patients with cirrhosis is very high, and a high percentage were caused by multidrug-resistant organisms, particularly in UTIs. The information provided might serve to adapt recommendations, particularly related to empirical antibiotic treatment in Argentina and Uruguay. The study was registered in Clinical Trials (NCT03919032).
Fil: Vazquez, Carolina. Hospital Italiano; Argentina
Fil: Gutierrez-Acevedo, María Nelly. Hospital 4 de Junio; Argentina
Fil: Barbero, Sabrina. Complejo Medico Policial Bartolome Churruca Andres Visca; Argentina
Fil: Notari, Lorena del Carmen. Complejo Medico Policial Bartolome Churruca Andres Visca; Argentina
Fil: Agozino, Marina. Sanatorio Guemes; Argentina
Fil: Fernandez, José Luis. Sanatorio Guemes; Argentina
Fil: Anders, María Margarita. Hospital Alemán; Argentina
Fil: Grigera, Nadia Lorena. Hospital Aleman; Argentina
Fil: Antinucci, Florencia. Hospital Alemán; Argentina
Fil: Orozco Ganem, Orlando Nicolas Federico. Hospital Alemán; Argentina
Fil: Murga, María Dolores. Hospital A. C. Padilla; Argentina
Fil: Perez, María Daniela. Hospital A. C. Padilla; Argentina
Fil: Palazzo, Ana Gracia. Hospital A. C. Padilla; Argentina
Fil: Rejtman, Liria Martinez. Hospital Teodoro J. Schestakow; Argentina
Fil: Duarte, Ivonne Giselle. Hospital 4 de Junio; Argentina
Fil: Vorobioff, Julio Daniel. Hospital Provincial del Centenario; Argentina
Fil: Trevizan, Victoria. Hospital Provincial del Centenario; Argentina
Fil: Bulaty, Sofía. Hospital Provincial del Centenario; Argentina
Fil: Bessone, Fernando. Hospital Provincial del Centenario; Argentina
Fil: Valverde, Marcelo. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Elizondo, Martín. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Borzi, Silvia Mabel. Hospital Prof. Rodolfo Rossi; Argentina
Fil: Stieben, Teodoro Eduardo. Provincia de Entre Rios. Hospital San Martin; Argentina
Fil: Masola, Adriano Carlos. Provincia de Entre Rios. Hospital San Martin; Argentina
Fil: Tomatis, Jesica. Hospital Privado de Rosario; Argentina
Fil: Pages, Josefina. Universidad Austral; Argentina
Fil: Tevez, Silvina. Sanatorio Guemes; Argentina
Fil: Gadano, Adrián Carlos. Hospital Italiano; Argentina
Fil: Giunta, Diego Hernan. Hospital Italiano; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Marciano, Sebastián. Hospital Italiano; Argentina
description Introduction and Objectives: there is insufficient data regarding bacterial infections in patients with cirrhosis to support recommendations for empiric antibiotic treatments, particularly in Latin America. This study aimed to evaluate bacterial infection's clinical impact and microbiological characteristics, intending to serve as a platform to revise current practices. Materials and Methods: multicenter prospective cohort study of patients with cirrhosis and bacterial infections from Argentina and Uruguay. Patient and infection-related information were collected, focusing on microbiology, antibiotic susceptibility patterns, and outcomes. Results: 472 patients were included. Spontaneous bacterial infections and urinary tract infections (UTIs) were registered in 187 (39.6%) and 116 (24.6%) patients, respectively, representing the most common infections. Of the 256 culture-positive infections, 103 (40.2%) were caused by multidrug-resistant organisms (reaching 50% for UTI), and 181 (70.7%) received adequate initial antibiotic treatment. The coverage of cefepime and ceftriaxone was over 70% for the empirical treatment of community-acquired spontaneous infections, but ceftazidime´s coverage was only 40%. For all UTI cases and for healthcare-associated or nosocomial spontaneous bacterial infections, the lower-spectrum antibiotics that covered at least 70% of the isolations were imipenem and meropenem. During hospitalization, a second bacterial infection was diagnosed in 9.8% of patients, 23.9% required at least one organ support, and 19.5% died. Conclusions: short-term mortality of bacterial infections in patients with cirrhosis is very high, and a high percentage were caused by multidrug-resistant organisms, particularly in UTIs. The information provided might serve to adapt recommendations, particularly related to empirical antibiotic treatment in Argentina and Uruguay. The study was registered in Clinical Trials (NCT03919032).
publishDate 2023
dc.date.none.fl_str_mv 2023-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/221031
Vazquez, Carolina; Gutierrez-Acevedo, María Nelly; Barbero, Sabrina; Notari, Lorena del Carmen; Agozino, Marina; et al.; Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay; Mexican Association of Hepatology; Annals of Hepatology; 28; 4; 7-2023; 1-8
1665-2681
CONICET Digital
CONICET
url http://hdl.handle.net/11336/221031
identifier_str_mv Vazquez, Carolina; Gutierrez-Acevedo, María Nelly; Barbero, Sabrina; Notari, Lorena del Carmen; Agozino, Marina; et al.; Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay; Mexican Association of Hepatology; Annals of Hepatology; 28; 4; 7-2023; 1-8
1665-2681
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1016/j.aohep.2023.101097
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1665268123002016
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Mexican Association of Hepatology
publisher.none.fl_str_mv Mexican Association of Hepatology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083496383086592
score 13.22299